Issue 11, 2021, Issue in Progress
From the journal:

RSC Advances

Retraction: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis

Laura Fishera  

a Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, UK
E-mail: advances-rsc@rsc.org

Abstract

Retraction of ‘Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis’ by Xingre Lu et al., 2019, 9, 37642–37651, DOI: 10.1039/C9RA07823A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1RA90073K
Article type
Retraction
Submitted
26 Jan 2021
Accepted
26 Jan 2021
First published
03 Feb 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 6254-6254

Permissions

Request permissions

Retraction: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis

L. Fisher, RSC Adv., 2021, 11, 6254 DOI: 10.1039/D1RA90073K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements